Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Oracle Enables Automation of Drug Supply Management Across Vendors and Studies to Help Speed and Simplify Clinical Trials
- 6/5/2025 7:32:53 AM
- New interoperability advancements in Oracle’s enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas.
- Global momentum on primary health care: Time to unite
- 6/4/2025 11:16:10 AM
- A major push to accelerate progress on primary health care (PHC) was emphasized at a side event during the seventy-eighth World Health Assembly in Geneva on 20 May 2025.
- Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
- 6/3/2025 10:29:59 AM
- Ad hoc announcement pursuant to Art. 53 LR • At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™ plus hormone therapy versus hormone therapy alone, with positive trend in overall survival (OS) 1 • Pluvicto is already approved for metastatic castration-resistant …
- Advocates Take to the Air to Raise Awareness About Congenital Lyme Disease
- 6/3/2025 8:29:10 AM
- A DC-based non-profit advertising agency collaborated with Mothers Against Lyme and Project Lyme on a strategic television advertising campaign to raise awareness about the risks and impact of congenital Lyme disease on mothers, children, and families.
- The Go-To Reference for Eye Care Professionals, Now Updated With the Latest Advancements in Ophthalmology - “Manual for Eye Examination and Diagnosis” (Eleventh Edition 2025) by Mark W. Leitman M.D
- 6/3/2025
- Reputable ophthalmologist Mark W. Leitman, M.D., has released his eleventh edition of the “Manual for Eye Examination and Diagnosis,” which provides medical professionals and students around the world with the most recent advancements in eye care education.
- Cardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study” for the Treatment of Severe Symptomatic Aortic Stenosis (sSAS)
- 6/2/2025 2:24:56 PM
- At the EuroPCR 2025 Congress - Paris Results confirm the promise of non-invasive ultrasound therapy (NIUT) previously observed in earlier clinical studies.
- Does a culturally tailored quality of life intervention benefit Latina breast cancer survivors and caregivers?
- 6/2/2025 2:02:16 PM
- A recent randomized controlled trial assessed the benefits of a group-based intervention that fosters communication and coping skills in a culturally tailored way for Latina breast cancer survivors and their caregivers.
- More physicians move to practices owned by hospitals & private equity groups
- 6/2/2025 1:59:36 PM
- Physicians continue to move away from private practices and increasingly work at practices owned by hospitals or private equity groups, according to the latest analysis (PDF) from the American Medical Association (AMA).
- Telehealth and Medicine Today Highlights Breakthrough Virtual Yoga and Mindfulness Program for TBI and Stroke in New Issue Showcasing Global Digital Health Innovations
- 6/2/2025 8:00:00 AM
- Telehealth and Medicine Today (THMT), the international peer reviewed journal in digital medicine, is proud to announce the release its latest issue, headlined by a groundbreaking study on a virtually adapted wellness program for adults with traumatic brain injury (TBI) or stroke and their caregivers.
- Blockchain in Healthcare Today® (BHTY) Launches Corporate Advisory Council
- 6/2/2025 8:00:00 AM
- Blockchain in Healthcare Today® (BHTY), the world’s first and only peer-reviewed journal dedicated to blockchain and decentralized technologies in healthcare, is proud to announce the launch of its Corporate Advisory Council — a strategic initiative inviting senior corporate leaders to help shape the future of scholarly publishing, innovation dialogue, and real-world …
- Study Links a Novel Biomarker with Potential to Predict and Treat Skin Cancer Metastasis
- 5/30/2025 9:24:05 AM
- Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.
- GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America
- 5/29/2025 7:31:29 AM
- GRIN also announces closing of $140 million Series D financing, including a $65 million strategic equity investment from Angelini Pharma and $75 million from existing investor Blackstone Life Sciences Collaboration combines Angelini Pharma’s global reach and focus on complex neurological disorders with GRIN’s expertise and capabilities in developing and advancing …
- Seventy-eighth World Health Assembly concludes: historic outcomes, consequential highlights
- 5/28/2025 9:39:29 AM
- The Seventy-eighth World Health Assembly (WHA78), the annual meeting of World Health Organization’s (WHO) Member States, came to a close Tuesday, as health leaders lauded vast accomplishments and global solidarity.
- Five Exceptional Researchers win the 2025 L’Oréal–UNESCO For Women in Science International Awards
- 5/28/2025 9:33:00 AM
- The Fondation L’Oréal and UNESCO are proud to announce the names of the five international laureates of the 2025 L’Oréal-UNESCO For Women in Science International Awards.
- Sanofi completes acquisition of DR-0201
- 5/28/2025 9:16:27 AM
- Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private clinical-stage biopharmaceutical company.
- Exhale Wellness Launches New THCp Gummies for Ultimate Euphoria & Relaxation
- 5/28/2025 4:04:30 AM
- Want to take your cannabis experience to the clouds? THCp gummies are where it’s at. Being 33x stronger than THC, these gummies will offer you a more intense high but with the convenience and tastiness of a gummy.
- Exhale Wellness Launches New Delta 9 Gummies for Euphoric and Cerebral Effects
- 5/28/2025 4:04:19 AM
- These Delta 9 gummies are literally the high vibe you’ve been waiting for. No cap. We’re talking premium, lab-tested edibles that move you on a cerebral level.
- Imfinzi recommended for approval in the EU by CHMP as first and only perioperative immunotherapy for muscle-invasive bladder cancer
- 5/27/2025 11:12:05 AM
- AstraZeneca’s Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).
- Esther Koplowitz and her Foundation distinguished as Honorary Protector Member by the Spanish Royal National Academy of Medicine
- 5/27/2025 2:13:42 AM
- As part of the second edition of the Academy Day, held at the headquarters of the Royal National Academy of Medicine of Spain (RANME), Esther Koplowitz and the Foundation she presides were recognised with the distinction of Honorary Protector Member, an award that values the trajectory, commitment and collaboration of institutions and individuals in favour of Spanish …
- Neuromorph Systems Launches Morphētype a Revolutionary AI Writing Studio to Redefine Drafting and Editing Experience
- 5/25/2025 5:04:07 PM
- Global prescriptions for GLP‑1 medications such as semaglutide and tirzepatide are on pace to exceed $50 billion annually, yet up to 30 percent of patients miss or delay at least one weekly dose in the first three months, eroding clinical outcomes and driving costly drug waste.